Literature DB >> 31971444

Involvement of small nerve fibres and autonomic nervous system in AL amyloidosis: comprehensive characteristics and clinical implications.

Panagiotis Kokotis1, Efstathios Manios2, Martin Schmelz3, Despina Fotiou2, Ioanna Dialoupi2, Maria Gavriatopoulou2, Maria Roussou2, Aikaterini Lykka2, Meletios A Dimopoulos2, Efstathios Kastritis2.   

Abstract

Peripheral nerve involvement in immunoglobulin light chain (AL) amyloidosis is common, characterised by severe progressive mixed neuropathy with autonomic dysfunction but there is limited data on the implications and the characteristics of small nerve fibres dysfunction (SNFD). The aim of our prospective study was to evaluate SNFD and its clinical implications in newly diagnosed AL patients. Twenty-three consecutive patients (10 male, mean age 61.78 years) and 21 age- and gender-matched healthy controls (8 male, mean age 61.28 years) underwent clinical evaluation and standard nerve conduction studies (NCS), baroreflex sensitivity (BRS) test, quantitative sensory testing (QST) and skin biopsy at the lower leg for measuring the density of the nerve fibres innervating the epidermis (IENFD). Axonal degeneration of the large nerve fibres was revealed in 15 out of 23 patients while SNFD was indicated by QST and skin biopsy in 56% and 61% of the patients respectively. BRS index significantly correlated with the IENFD and the QST results while low IENFD was associated with significantly poorer survival. Our study provides new insights and also an initial evaluation of new tools for assessment of the involvement of autonomic and small nerve fibres in AL amyloidosis. These findings also appear to have prognostic implications.

Entities:  

Keywords:  AL amyloidosis; autonomic dysfunction; clinical implications; prognosis; small nerve fibres dysfunction

Mesh:

Year:  2020        PMID: 31971444     DOI: 10.1080/13506129.2020.1713081

Source DB:  PubMed          Journal:  Amyloid        ISSN: 1350-6129            Impact factor:   7.141


  3 in total

Review 1.  Arrhythmic Sudden Cardiac Death and the Role of Implantable Cardioverter-Defibrillator in Patients with Cardiac Amyloidosis-A Narrative Literature Review.

Authors:  Aleksandra Liżewska-Springer; Grzegorz Sławiński; Ewa Lewicka
Journal:  J Clin Med       Date:  2021-04-25       Impact factor: 4.241

2.  Corneal confocal microscopy to detect early immune-mediated small nerve fibre loss in AL amyloidosis.

Authors:  Mark Stettner; Tim Hagenacker; Andreas Thimm; Alexander Carpinteiro; Sara Oubari; Maria Papathanasiou; Lukas Kessler; Christoph Rischpler; Rayaz Ahmed Malik; Hans Christian Reinhardt; Tienush Rassaf; Ken Herrmann; Christoph Kleinschnitz
Journal:  Ann Clin Transl Neurol       Date:  2022-04-30       Impact factor: 5.430

Review 3.  Challenges in the management of patients with systemic light chain (AL) amyloidosis during the COVID-19 pandemic.

Authors:  Efstathios Kastritis; Ashutosh Wechalekar; Stefan Schönland; Vaishali Sanchorawala; Giampaolo Merlini; Giovanni Palladini; Monique Minnema; Murielle Roussel; Arnaud Jaccard; Ute Hegenbart; Shaji Kumar; Maria T Cibeira; Joan Blade; Meletios A Dimopoulos
Journal:  Br J Haematol       Date:  2020-07-04       Impact factor: 8.615

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.